中华危重病急救医学
中華危重病急救醫學
중화위중병급구의학
Chinese Critical Care Medicine
2015年
9期
735-738
,共4页
鹿兴%李彤%李军%高心晶%徐磊
鹿興%李彤%李軍%高心晶%徐磊
록흥%리동%리군%고심정%서뢰
严重脓毒症%脓毒性休克%集束化治疗%早期目标导向治疗%病死率
嚴重膿毒癥%膿毒性休剋%集束化治療%早期目標導嚮治療%病死率
엄중농독증%농독성휴극%집속화치료%조기목표도향치료%병사솔
Severe sepsis%Septic shock%Bundle%Early goal-directed therapy%Mortality
目的:评价早期目标导向治疗(EGDT)对严重脓毒症或脓毒性休克患者病死率的影响。方法计算机检索1980年1月至2015年5月美国国立医学图书馆PubMed数据库、Cochrane临床试验数据库、荷兰医学文摘EMBASE数据库、万方数据库和中国知网数据库有关文献。纳入标准:研究对象为成人严重脓毒症或脓毒性休克患者;试验设计为随机对照试验(RCT)、半随机对照试验(CCT)、病例对照研究(CCS)、队列研究,且数据资料齐全;研究指标为短期病死率〔院内、重症加强治疗病房(ICU)、28 d〕、远期病死率(60 d、90 d或1年)。采用RevMan 5.2软件进行EGDT治疗对严重脓毒症或脓毒性休克患者病死率影响的Meta分析,并绘制漏斗图评价文献发表偏倚情况。结果最终纳入12篇文献、5528例患者,其中4篇为RCT,3篇为前后对照观察研究,4篇为队列研究,1篇为准实验研究。Meta分析显示,EGDT可降低严重脓毒症或脓毒性休克患者的短期病死率〔相对危险度(RR)=0.72,95%可信区间(95%CI)=0.64~0.80,P=0.00001〕,但对于降低远期病死率无影响(RR=0.99,95%CI=0.92~1.06,P=0.81)。漏斗图显示,12篇文献不存在发表偏倚。EGDT推荐级别为C级。结论 EGDT能降低严重脓毒症或脓毒性休克患者的短期病死率,但对远期病死率无影响,推荐级别为C级。
目的:評價早期目標導嚮治療(EGDT)對嚴重膿毒癥或膿毒性休剋患者病死率的影響。方法計算機檢索1980年1月至2015年5月美國國立醫學圖書館PubMed數據庫、Cochrane臨床試驗數據庫、荷蘭醫學文摘EMBASE數據庫、萬方數據庫和中國知網數據庫有關文獻。納入標準:研究對象為成人嚴重膿毒癥或膿毒性休剋患者;試驗設計為隨機對照試驗(RCT)、半隨機對照試驗(CCT)、病例對照研究(CCS)、隊列研究,且數據資料齊全;研究指標為短期病死率〔院內、重癥加彊治療病房(ICU)、28 d〕、遠期病死率(60 d、90 d或1年)。採用RevMan 5.2軟件進行EGDT治療對嚴重膿毒癥或膿毒性休剋患者病死率影響的Meta分析,併繪製漏鬥圖評價文獻髮錶偏倚情況。結果最終納入12篇文獻、5528例患者,其中4篇為RCT,3篇為前後對照觀察研究,4篇為隊列研究,1篇為準實驗研究。Meta分析顯示,EGDT可降低嚴重膿毒癥或膿毒性休剋患者的短期病死率〔相對危險度(RR)=0.72,95%可信區間(95%CI)=0.64~0.80,P=0.00001〕,但對于降低遠期病死率無影響(RR=0.99,95%CI=0.92~1.06,P=0.81)。漏鬥圖顯示,12篇文獻不存在髮錶偏倚。EGDT推薦級彆為C級。結論 EGDT能降低嚴重膿毒癥或膿毒性休剋患者的短期病死率,但對遠期病死率無影響,推薦級彆為C級。
목적:평개조기목표도향치료(EGDT)대엄중농독증혹농독성휴극환자병사솔적영향。방법계산궤검색1980년1월지2015년5월미국국립의학도서관PubMed수거고、Cochrane림상시험수거고、하란의학문적EMBASE수거고、만방수거고화중국지망수거고유관문헌。납입표준:연구대상위성인엄중농독증혹농독성휴극환자;시험설계위수궤대조시험(RCT)、반수궤대조시험(CCT)、병례대조연구(CCS)、대렬연구,차수거자료제전;연구지표위단기병사솔〔원내、중증가강치료병방(ICU)、28 d〕、원기병사솔(60 d、90 d혹1년)。채용RevMan 5.2연건진행EGDT치료대엄중농독증혹농독성휴극환자병사솔영향적Meta분석,병회제루두도평개문헌발표편의정황。결과최종납입12편문헌、5528례환자,기중4편위RCT,3편위전후대조관찰연구,4편위대렬연구,1편위준실험연구。Meta분석현시,EGDT가강저엄중농독증혹농독성휴극환자적단기병사솔〔상대위험도(RR)=0.72,95%가신구간(95%CI)=0.64~0.80,P=0.00001〕,단대우강저원기병사솔무영향(RR=0.99,95%CI=0.92~1.06,P=0.81)。루두도현시,12편문헌불존재발표편의。EGDT추천급별위C급。결론 EGDT능강저엄중농독증혹농독성휴극환자적단기병사솔,단대원기병사솔무영향,추천급별위C급。
ObjectiveTo investigate whether early goal-directed therapy (EGDT) could improve the mortality rate in patients with severe sepsis or septic shock.Methods Articles were retrieved from PubMed, Cochrane Library, Embase data, Wanfang data, and CNKI from January 1980 to May 2015. Inclusion criteria included the subjects concerning patients with severe sepsis or septic shock reported as randomized controlled trial (RCT), clinical controlled trial (CCT), case-control studies, cohort studies with complete data, which endpoints were the short-term mortality [in-hospital, intensive care unit (ICU) or 28-day] and long-term mortality (60-day, 90-day or 1 year). RevMan 5.2 software was used for Meta analysis of effect of EGDT on mortality rate in patients with severe sepsis or septic shock, and funnel plot was drawn to evaluate the quality of enrolled literature.Results There were 12 studies meeting inclusive criteria including 5 528 patients, 4 RCTs, 3 case-control studies, 4 cohort studies, and 1 quasi-experimental research. It was shown by Meta analysis that EGDT was associated with significant decrease in the short-term mortality [relative risk (RR) = 0.72, 95% confidence interval (95%CI) = 0.64-0.80,P< 0.000 01], but not associated with decrease of long-term mortality (RR = 0.99, 95%CI = 0.92-1.06,P = 0.81). The funnel plot showed that there was no publication bias. EGDT was recommended as grade C.Conclusions EGDT was associated with significant improvement in short-term mortality but not with long-term mortality in patients with severe sepsis or septic shock. Grade C was recommended by our study.